Patent · US Active

Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases

US8796244B2 · kind B2 · utility

1Cited by
17References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2009
Grant dateAug 5, 2014
Priority date
Expiry dateSep 12, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to new bicyclic heterocyclic derivative compounds, to pharmaceutical compositions comprising the compounds and to the use of the compounds in the treatment of diseases, e.g. cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.